A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Smallpox (Vaccinia) Vaccine, Live
The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Adenovirus type 7 vaccine live
The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Human adenovirus e serotype 4 strain cl-68578 antigen
The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Typhoid vaccine
The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Varicella Zoster Vaccine (Recombinant)
The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
BCG vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Tecemotide
The therapeutic efficacy of Tecemotide can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Bacillus calmette-guerin substrain danish 1331 live antigen
The therapeutic efficacy of Bacillus calmette-guerin substrain danish 1331 live antigen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Hepatitis B Vaccine (Recombinant)
The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Human rabies virus immune globulin
The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Typhoid Vaccine Live
The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Prednisolone acetate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3